HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsunori Saikawa Selected Research

Warfarin (Coumadin)

6/2016Regional Differences in Frequency of Warfarin Therapy and Thromboembolism in Japanese Patients With Non-Valvular Atrial Fibrillation　- Analysis of the J-RHYTHM Registry.
8/2015Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry.
1/2013Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsunori Saikawa Research Topics

Disease

26Insulin Resistance
08/2012 - 09/2003
14Type 2 Diabetes Mellitus (MODY)
08/2012 - 10/2004
13Atrial Fibrillation
10/2020 - 09/2003
13Reperfusion Injury
01/2016 - 10/2002
10Ischemia
03/2011 - 10/2002
7Fibrosis (Cirrhosis)
01/2016 - 11/2007
7Hyperthermia
01/2012 - 08/2006
5Inflammation (Inflammations)
01/2016 - 01/2008
5Ventricular Tachycardia
01/2011 - 11/2003
5Cerebral Infarction
10/2008 - 09/2003
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 03/2004
4Heart Diseases (Heart Disease)
01/2012 - 09/2004
4Hypertension (High Blood Pressure)
04/2011 - 10/2006
4Chronic Kidney Failure (Chronic Renal Failure)
10/2008 - 05/2006
4Atherosclerosis
01/2008 - 09/2007
4Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
02/2007 - 09/2003
3Cardiovascular Diseases (Cardiovascular Disease)
01/2024 - 09/2008
3Hemorrhage
08/2015 - 09/2003
3Diabetes Mellitus
10/2014 - 05/2012
3Infarction (Infarctions)
07/2012 - 05/2009
3Myocardial Infarction
01/2011 - 02/2009
3Heart Failure
01/2011 - 09/2003
3Essential Hypertension
08/2008 - 07/2005
2Hypercholesterolemia
01/2024 - 01/2012
2Thromboembolism
06/2016 - 08/2015
2Cognitive Dysfunction
07/2011 - 04/2011
2Cardiac Arrhythmias (Arrythmia)
01/2011 - 05/2005
2Stroke (Strokes)
01/2011 - 07/2010
2Glucose Intolerance
08/2008 - 06/2008
2Hypoxia (Hypoxemia)
07/2007 - 05/2006
2Hyperhomocysteinemia
01/2007 - 05/2006
1Atrial Remodeling
01/2016
1Starvation
01/2016
1Diabetes Complications
01/2016
1Thrombosis (Thrombus)
01/2013
1Sarcoidosis (Schaumann Disease)
04/2012

Drug/Important Bio-Agent (IBA)

22Insulin (Novolin)FDA Link
01/2016 - 10/2002
9HSP72 Heat-Shock ProteinsIBA
12/2011 - 07/2003
8Glucose (Dextrose)FDA LinkGeneric
01/2016 - 07/2005
7Angiotensin IIIBA
04/2013 - 06/2004
6C-Reactive ProteinIBA
10/2011 - 04/2005
4LipidsIBA
01/2024 - 12/2004
4Streptozocin (Streptozotocin)FDA Link
01/2016 - 10/2002
4Pioglitazone (Actos)FDA Link
01/2012 - 08/2006
4candesartanIBA
12/2011 - 06/2004
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2011 - 02/2009
4geranylgeranylacetone (teprenone)IBA
09/2007 - 07/2003
3LDL CholesterolIBA
01/2024 - 06/2008
3Ezetimibe (Zetia)FDA Link
01/2024 - 01/2012
3Warfarin (Coumadin)FDA LinkGeneric
06/2016 - 01/2013
3AnticoagulantsIBA
08/2015 - 10/2010
3Reactive Oxygen Species (Oxygen Radicals)IBA
10/2014 - 07/2010
3AntioxidantsIBA
12/2012 - 03/2011
3AdiponectinIBA
08/2012 - 07/2007
3Pravastatin (Pravachol)FDA LinkGeneric
01/2012 - 06/2010
3Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
12/2011 - 08/2006
3Phosphatidylinositols (Phosphatidylinositol)IBA
12/2011 - 08/2006
3HomocysteineIBA
07/2011 - 10/2007
3Angiotensin Receptor AntagonistsIBA
04/2011 - 06/2004
3CalciumIBA
01/2011 - 03/2004
3Creatine Kinase (Creatine Phosphokinase)IBA
05/2009 - 11/2003
3HDL CholesterolIBA
06/2008 - 02/2007
3AlbuminsIBA
09/2007 - 10/2004
2CholesterolIBA
01/2024 - 01/2012
2Protein Kinase CIBA
10/2020 - 11/2003
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2012 - 02/2011
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2012 - 07/2005
2Amlodipine (Norvasc)FDA LinkGeneric
04/2011 - 10/2006
2Anti-Arrhythmia AgentsIBA
01/2011 - 10/2006
2Valsartan (Vals)FDA Link
09/2010 - 07/2005
2mitochondrial K(ATP) channelIBA
05/2009 - 09/2007
2AdrenomedullinIBA
03/2009 - 06/2005
2Atorvastatin (Lipitor)FDA Link
02/2009 - 06/2008
2Angiotensin II Type 1 Receptor BlockersIBA
10/2006 - 09/2004
2Glyburide (Glibenclamide)FDA LinkGeneric
08/2006 - 11/2003
1Phytosterols (Plant Sterols)IBA
01/2024
1campesterolIBA
01/2024
1Phosphotransferases (Kinase)IBA
10/2020
1GlycogenIBA
10/2020
1Interleukin-10 (Interleukin 10)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
1Factor Xa InhibitorsIBA
08/2015
1CollagenIBA
10/2014
1Collagen Type I (Type I Collagen)IBA
10/2014
1LeptinIBA
04/2013
1SmokeIBA
01/2013
1NADPH Oxidases (NAD(P)H oxidase)IBA
12/2012
1AdipokinesIBA
08/2012
1ResveratrolIBA
07/2012
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
05/2012
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2012

Therapy/Procedure

8Therapeutics
06/2016 - 09/2003
4Renal Dialysis (Hemodialysis)
10/2008 - 05/2006
2Catheter Ablation
01/2013 - 02/2009
2Intravenous Administration
01/2007 - 09/2003
2Induced Hyperthermia (Thermotherapy)
05/2006 - 11/2004
2Oral Administration
06/2005 - 07/2003
1Splenectomy
01/2016
1Electric Countershock (Cardioversion)
01/2013